Cargando…
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
Pharmaceutical companies regularly fund patient organizations. It is important for patient organizations’ credibility that there be transparency regarding this financial support. In Europe, the pharmaceutical industry promises to deliver transparency through self-regulation, as opposed to legally bi...
Autores principales: | Pashley, Dylan, Ozieranski, Piotr, Mulinari, Shai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203660/ https://www.ncbi.nlm.nih.gov/pubmed/35230175 http://dx.doi.org/10.1177/00207314221083871 |
Ejemplares similares
-
Canada and the pharmaceutical industry in the time of COVID-19
por: Lexchin, Joel
Publicado: (2023) -
A Proposal to Increase Value and Equity in the Development and Distribution of New Pharmaceuticals
por: Sorum, Paul, et al.
Publicado: (2022) -
Exposing drug industry funding of UK patient organisations
por: Ozieranski, Piotr, et al.
Publicado: (2019) -
Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020) -
Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)